The McGill-R-Thy1-APP transgenic rat line, harboring the AβPP Swe × AβPP Ind mutations, provides a more comprehensive model of amyloid pathology, closely resembling Alzheimer’s disease. This evidence concerns the gene APP and Alzheimer disease.